More about

Cancer

News
November 11, 2013
2 min read
Save

PARP inhibitor shows promise in treatment of breast, ovarian cancers

The novel PARP inhibitor BMN 673 improved response in patients with BRCA-related breast and ovarian cancers, according to study results presented at the International Conference on Molecular Targets and Cancer Therapeutics.

News
November 11, 2013
2 min read
Save

P-S6 potential ‘functional’ biomarker in BRAF-mutant melanoma

Suppression of the phosphorylation of the protein S6 after the initiation of RAF inhibitor therapy may serve as a functional biomarker to guide the treatment of patients with BRAF-mutant melanoma, according to study results presented at the International Conference on Molecular Targets and Cancer Therapeutics.

News
November 06, 2013
1 min read
Save

Antibody-drug conjugate demonstrated activity against guanylyl cyclase C in pancreatic cancer

The antibody-drug conjugate MLN0264 demonstrated antitumor activity in pancreatic cancer xenograft models, according to study results presented at the International Conference on Molecular Targets and Cancer Therapeutics.

News
November 06, 2013
2 min read
Save

New technology accurately detected BRAF mutations in tissue samples

New technology accurately detected BRAF mutations in tissue samples

A new molecular diagnostic prototype platform detected BRAF mutations in cancer tissue samples faster and more accurately vs. Clinical Laboratory Improvement Amendments-approved lab results, according to findings presented at the International Conference on Molecular Targets and Cancer Therapeutics.

News
October 29, 2013
3 min read
Save

Online chats allow patients, physicians and advocates to share insights, experiences

Online chats allow patients, physicians and advocates to share insights, experiences

I have written previously about the ability of Twitter to facilitate conversations around topics relevant to hematology and oncology.

News
October 29, 2013
1 min read
Save

Dinaciclib potential inhibitor of tumor growth in pancreatic cancer

The novel agent dinaciclib demonstrated activity in xenographic models against the RAS pathway of the KRAS mutation associated with pancreatic cancer, according to study results presented at the International Congress on Molecular Targets and Cancer Therapeutics.

News
October 28, 2013
2 min read
Save

CRLX101 plus bevacizumab demonstrated activity against HIF-1 alpha

CRLX101 combined with antiangiogenic therapy inhibited the upregulation of hypoxia-inducible factor 1 alpha, according to findings presented at the International Conference on Molecular Targets and Cancer Therapeutics.

News
September 21, 2013
3 min read
Save

Screening strategy identified ovarian cancer early in postmenopausal women

A new two-stage ovarian cancer screening strategy that incorporates a carbohydrate antigen 125 blood test and Risk of Ovarian Cancer Algorithm calculation achieved high specificity with few false-positive results in a cohort of postmenopausal women, according to results of an 11-year study.

News
March 07, 2012
1 min read
Save

Delirium common among hospitalized patients with advanced cancer

Delirium is common in hospitalized patients with advanced cancer and many factors contribute to its cause, according to findings of a retrospective study.

View more